{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:27:50Z","timestamp":1793136470788,"version":"4.5.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,1]]},"abstract":"<jats:p>Left ventricle and aortic valve underdevelopment are presentations in the congenital cardiac condition hypoplastic left heart syndrome (HLHS); current clinical treatments involve right ventricle refunctionalization. Cardiac organoid models provide simplified open chambers engineered into a flow loop, to ameliorate ventricle-type function. Complete bioengineered ventricle development presents a significant advancement in cardiac organoids. This study provides the foundation for bioengineered complete ventricle (BECV) fabrication. Bioengineered trileaflet valve (BETV) molds and chitosan scaffolds were developed to emulate human neonate aortic valve geometry. Bioengineered complete ventricle were fabricated by fitting BETV into a bioengineered open ventricle (BEOV); the chamber was cellularized using a two-stage cellularization strategy, and BETV were passively seeded with rat neonatal cardiac fibroblasts and perfusion cultured for 3 days. Average pressure generated ranged from 0.06 to 0.12\u2009mm Hg; average biopotential output was 1.02 mV. Histologic assessment displayed syncytial-type cardiomyocyte aggregates at the BECV chamber surface; BETV displayed randomly oriented, diffusely distributed cardiac fibroblasts. The fabrication of this novel BECV may aid in developing a functional engineered left ventricle for clinical application in HLHS.<\/jats:p>","DOI":"10.1097\/mat.0000000000000642","type":"journal-article","created":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T21:10:09Z","timestamp":1504300209000},"page":"56-62","source":"Crossref","is-referenced-by-count":21,"title":["The Bioengineered Cardiac Left Ventricle"],"prefix":"10.1097","volume":"64","author":[{"given":"Nikita M.","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi K.","family":"Birla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230821","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0140-6736(09)60563-8","article-title":"Hypoplastic left heart syndrome.","volume":"374","author":"Barron","year":"2009","journal-title":"Lancet"},{"key":"R2-20230821","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1161\/hh0202.103644","article-title":"Tissue engineering of a differentiated cardiac muscle construct.","volume":"90","author":"Zimmerman","year":"2002","journal-title":"Circ Res"},{"key":"R3-20230821","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.trim.2003.12.010","article-title":"Heart valve tissue engineering.","volume":"12","author":"Neuenschwander","year":"2004","journal-title":"Transpl Immunol"},{"key":"R4-20230821","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1161\/CIRCULATIONAHA.104.498378","article-title":"From stem cells to viable autologous semilunar heart valve.","volume":"111","author":"Sutherland","year":"2005","journal-title":"Circulation"},{"key":"R5-20230821","first-page":"89","article-title":"Tissue engineered aortic valve.","volume":"4","author":"Dohmen","year":"2012","journal-title":"HSR Proc Intensive Care Cardiovasc Anesth"},{"key":"R6-20230821","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jmbbm.2011.08.021","article-title":"Improving the mechanical properties of chitosan-based heart valve scaffolds using chitosan fibers.","volume":"5","author":"Albanna","year":"2012","journal-title":"J Mech Behav Biomed Mater"},{"key":"R7-20230821","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1007\/s10439-006-9163-z","article-title":"Heart valve tissue engineering: Concepts, approaches, progress, and challenges.","volume":"34","author":"Mendelson","year":"2006","journal-title":"Ann Biomed Eng"},{"key":"R8-20230821","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1089\/tea.2007.0351","article-title":"Engineered cardiac organoid chambers: Toward a functional biological model ventricle.","volume":"14","author":"Lee","year":"2008","journal-title":"Tissue Eng Part A"},{"key":"R9-20230821","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nm1684","article-title":"Perfusion-decellularized matrix: Using nature\u2019s platform to engineer a bioartificial heart.","volume":"14","author":"Ott","year":"2008","journal-title":"Nat Med"},{"key":"R10-20230821","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1196\/annals.1302.025","article-title":"Controlling the cellular organization of tissue-engineered cardiac constructs.","volume":"1015","author":"Gonen-Wadmany","year":"2004","journal-title":"Ann N Y Acad Sci"},{"key":"R11-20230821","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2217\/17460751.2.4.391","article-title":"Cell-based cardiac pumps and tissue-engineered ventricles.","volume":"2","author":"Khait","year":"2007","journal-title":"Regen Med"},{"key":"R12-20230821","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1039\/B612082B","article-title":"A micro-spherical heart pump powered by cultured cardiomyocytes.","volume":"7","author":"Tanaka","year":"2007","journal-title":"Lab Chip"},{"key":"R13-20230821","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1002\/jbm.b.33742","article-title":"The design and fabrication of a three-dimensional bioengineered open ventricle.","volume":"105","author":"Patel","year":"2017","journal-title":"J Biomed Mater Res B Appl Biomater"},{"key":"R14-20230821","first-page":"203","article-title":"Functional characterization of chitin and chitosan.","volume":"3","author":"Aranaz","year":"2009","journal-title":"Current Chemical Biology"},{"key":"R15-20230821","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1002\/bit.25992","article-title":"Optimizing cell seeding and retention in a three-dimensional bioengineered cardiac ventricle: The two-stage cellularization model.","volume":"113","author":"Patel","year":"2016","journal-title":"Biotechnol Bioeng"},{"key":"R16-20230821","doi-asserted-by":"crossref","first-page":"015003","DOI":"10.1088\/1758-5090\/9\/1\/015003","article-title":"Pulsatile flow conditioning of three-dimensional bioengineered cardiac ventricle.","volume":"9","author":"Patel","year":"2016","journal-title":"Biofabrication"},{"key":"R17-20230821","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/jbm.a.31090","article-title":"Contractile three-dimensional bioengineered heart muscle for myocardial regeneration.","volume":"80","author":"Huang","year":"2007","journal-title":"J Biomed Mater Res A"},{"key":"R18-20230821","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/term.1895","article-title":"Optimizing a spontaneously contracting heart tissue patch with rat neonatal cardiac cells on fibrin gel.","volume":"11","author":"Tao","year":"2017","journal-title":"J Tissue Eng Regen Med"},{"key":"R19-20230821","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/bit.10594","article-title":"High-density seeding of myocyte cells for cardiac tissue engineering.","volume":"82","author":"Radisic","year":"2003","journal-title":"Biotechnol Bioeng"},{"key":"R20-20230821","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1161\/01.RES.35.6.871","article-title":"Dimensions and geometric relationships of the human aortic valve as a function of pressure.","volume":"35","author":"Swanson","year":"1974","journal-title":"Circ Res"},{"key":"R21-20230821","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/0735-1097(93)90323-S","article-title":"Left ventricular diastolic dysfunction late after coarctation repair in childhood: Influence of left ventricular hypertrophy.","volume":"21","author":"Krogmann","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"R22-20230821","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1109\/TBME.2015.2399437","article-title":"32-channel system to measure the electrophysiological properties of bioengineered cardiac muscle.","volume":"62","author":"Salazar","year":"2015","journal-title":"IEEE Trans Biomed Eng"},{"key":"R23-20230821","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1161\/01.RES.0000100389.57520.1A","article-title":"Developmental changes in ventricular diastolic function correlate with changes in ventricular myoarchitecture in normal mouse embryos.","volume":"93","author":"Ishiwata","year":"2003","journal-title":"Circ Res"},{"key":"R24-20230821","doi-asserted-by":"crossref","first-page":"72","DOI":"10.2353\/ajpath.2006.051163","article-title":"Cardiac conduction through engineered tissue.","volume":"169","author":"Choi","year":"2006","journal-title":"Am J Pathol"},{"key":"R25-20230821","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1152\/ajplegacy.1968.214.1.197","article-title":"QRS-T variations in the rat electrocardiogram.","volume":"214","author":"Beinfield","year":"1968","journal-title":"Am J Physiol"}],"container-title":["ASAIO Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00002480-201801000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T00:54:17Z","timestamp":1692665657000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002480-201801000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/mat.0000000000000642","relation":{},"ISSN":["1058-2916"],"issn-type":[{"value":"1058-2916","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]}}}